Cargando…
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
More effective therapy for patients with either muscle‐invasive or high‐risk non‐muscle‐invasive urothelial carcinoma of the bladder (UCB) is an unmet clinical need. For this, drug repositioning of clinically approved drugs represents an interesting approach. By repurposing existing drugs, alternati...
Autores principales: | van der Horst, Geertje, van de Merbel, Arjanneke F., Ruigrok, Eline, van der Mark, Maaike H., Ploeg, Emily, Appelman, Laura, Tvingsholm, Siri, Jäätelä, Marja, van Uhm, Janneke, Kruithof‐de Julio, Marianna, Thalmann, George N., Pelger, Rob C. M., Bangma, Chris H., Boormans, Joost L., van der Pluijm, Gabri, Zwarthoff, Ellen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718956/ https://www.ncbi.nlm.nih.gov/pubmed/32896947 http://dx.doi.org/10.1002/1878-0261.12793 |
Ejemplares similares
-
An ex vivo Tissue Culture Model for the Assessment of Individualized Drug Responses in Prostate and Bladder Cancer
por: van de Merbel, Arjanneke F., et al.
Publicado: (2018) -
The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis
por: van den Hoogen, Christel, et al.
Publicado: (2011) -
The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers
por: van de Merbel, Arjanneke F., et al.
Publicado: (2021) -
Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma
por: van der Horst, Geertje, et al.
Publicado: (2014) -
miR-25, integrin and cancer invasiveness
por: Zoni, Eugenio, et al.
Publicado: (2015)